Ireland· IE-PA-PA0749/065/001
Naraverg 2.5 mg Film-coated Tablets
A naratriptan product containing naratriptan, registered in Ireland by Teva Pharma B.V.. The same ATC class is registered in 15 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Naratriptan is registered in 15 of 19 countries.
Countries holding a registration under ATC N02CC02 (naratriptan), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 8 of them publish a price we can compare per daily dose
Naratriptan · ATC N02CC02
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Ireland
- Netherlands
- Norwayprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of naratriptan costs, country by country.
Normalised to the WHO defined daily dose (2.5 mg), the median price runs from $1.25 in France to $6.45 in Switzerland — a ×5.2 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Naratriptan · price per daily dose (2.5 mg)
USD · FX 28 Sept 2026
- CH Switzerland$6.45
- ES Spain$3.63
- FR France$1.25
The record
At a glance
HPRA (Ireland)- Active substance
- Naratriptan
- Manufacturer
- Teva Pharma B.V.
- Country
- Ireland (IE)
- ATC code
- N02CC02
- ATC class
- Naratriptan
- Defined daily dose
- 2.5 mg, O
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPA0749/065/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
50 interactions on record for naratriptan.
Graded by severity as the source publishes them — 11 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Naratriptan · interactions on record
50 records
- 11 severe
- 6 moderate
- 5 minor
- 27 info
Most severe, free to view
- OndansetronA04AA01severe
- GranisetronA04AA02severe
- DolasetronA04AA04severe
- PalonosetronA04AA05severe
1 more interaction with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Naratriptan in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaNARAMIGGlaxoSmithKline Trading Services Limited, Dublin
- FranceNARAMIG 2,5 mg, comprimé pelliculéGLAXOSMITHKLINE
- SwedenNaramig 2,5 mg Filmdragerad tablettGlaxoSmithKline AB
- FinlandNaramigParanova Oy
- NetherlandsNaramig, filmomhulde tabletten 2,5 mgGlaxoSmithKline B.V.
- BelgiumNaramig 2.5 mgGlaxoSmithKline Pharmaceuticals
- NorwayNaramig2care4 ApS
- United StatesNaratriptanBionpharma Inc.
Authorised across Europe · EMA
The same active substance is authorised in 18 EEA countries. Names it is sold under:
- Belgium · Naramig, Naratriptan Sandoz
- Bulgaria · Нарворан Мигрена
- Czechia · Naramig
- Germany · Formigran, Naradex
- Denmark · Naratriptan Teva, Naxtrin
- Spain · Naramig
- Finland · Naramig, Naratriptan Orifarm
- France · Naramig, Naratriptan Arrow
- United Kingdom (Northern Ireland) · Naramig, Naratriptan
- Lithuania · Naramig, Naratriptan Inteli
- Luxembourg · Naramig
- Malta · Naratriptan Renata Pharmaceuticals (Ireland)
- Netherlands · Naramig, Naratriptan Cf
- Norway · Naratriptan Orifarm, Naxtrin
- Portugal · Naramig, Naratriptano Renata
- Romania · Nacralid, Naratriptan Stada Hemofarm
- Sweden · Naramig, Naratriptan Orifarm
- Slovenia · Naramig
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/62399d92-0736-4e65-922d-ea71cd363d8a GET /v1/drugs/62399d92-0736-4e65-922d-ea71cd363d8a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Film-coated tablet",
"routes": [
"Oral use"
],
"source": "hpra",
"atc_all": [
"N02CC",
"N02CC02"
],
"strength": null,
"pa_number": "PA0749/065/001",
"substances": [
"Naratriptan"
],
"legal_basis": "Generic application (Article 10(1) of Directive No 2001/83/EC)",
"market_info": "Marketed",
"authorised_at": "16/05/2008",
"dispensing_status": "Product subject to prescription which may be renewed (B)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about naratriptan.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.